Innovative Imaging Technology Digirad's solid-state detector technology in nuclear medicine imaging systems positions it as a leader in advanced medical imaging solutions, offering high reliability and improved diagnostic capabilities that appeal to imaging centers seeking cutting-edge equipment.

Recent Acquisitions With recent mergers and acquisitions, such as Ultrascan group and ATRM Holdings, Digirad has expanded its product portfolio and market reach, creating opportunities for partners to enter a diversified and growing diagnostic imaging market.

Financial Growth Potential Generating between 50 to 100 million dollars in revenue, Digirad presents a solid financial foundation and growth potential, making it an attractive prospect for suppliers and collaborators looking to target a mid-sized medical equipment manufacturer.

Market Expansion Opportunities The company's investment in manufacturing assets in Maine and its recent product updates suggest ongoing capacity expansion and innovation, creating opportunities for equipment suppliers, component manufacturers, and service providers to collaborate on growth initiatives.

Industry Leadership & Visibility Led by experienced leadership including CEO Matt Molchan, Digirad's strategic focus and market presence in nuclear imaging equipment provide a strong platform for strategic partnerships and commercial collaborations within the medical imaging industry.